Full-Time

Mechanical Engineer Group Lead

Deadline 5/28/27
IPS-Integrated Project Services, LLC

IPS-Integrated Project Services, LLC

1,001-5,000 employees

Integrated design, engineering, construction management

Compensation Overview

$150k - $230k/yr

Emeryville, CA, USA

In Person

Travel duration depends on project location; the position includes field work at client sites.

Bachelor's

Category
Mechanical Engineering (1)
Required Skills
HVAC

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Requirements
  • A Bachelor's degree in Mechanical Engineering from an accredited university is required.
  • At least 10 years of professional engineering experience in mechanical design, including heating, ventilation, and air-conditioning and utilities, is required.
  • Registration as a Professional Engineer is required.
  • Knowledge of local codes and industry-standard equipment, including the ability to specify equipment for proper applications, is required.
  • The position is safety-sensitive and requires field work at client sites.
Responsibilities
  • Lead and grow a small team of mechanical engineers.
  • Work independently on multiple projects concurrently as assigned by a Project Manager.
  • Oversee aspects of or the entire heating, ventilation, and air-conditioning and utilities design process, or serve as a technical expert on specialized designs.
  • Write scopes of work for mechanical designs based on preliminary reviews and client meetings.
  • Prepare engineering studies and schematic designs for new heating, ventilation, and air-conditioning and utilities systems.
  • Analyze the operation of existing systems.
  • Assess project requirements, break them into tasks, and work with Project Managers to determine scope of work, budget, and staffing.
  • Review mechanical progress and alert the Project Manager to changes in scope.
  • Maintain quality in accordance with company production and design standards.
  • Work with the Regional Director of Design and the Human Resources team to recruit and retain talent and develop staffing plans.
  • Oversee manpower planning to ensure efficient assignment of resources across multiple concurrent projects.
  • Provide team members with training and career development opportunities.
  • Prepare estimates, review contractor payment applications, review construction budgets, and coordinate document completion.
  • Connect with clients to ensure satisfaction and build relationships.
Desired Qualifications
  • Experience in the pharmaceutical, biotechnology, life sciences, or laboratory industries is preferred but not required.
IPS-Integrated Project Services, LLC

IPS-Integrated Project Services, LLC

View

IPS provides design, engineering, and construction management for complex facilities, especially in the pharmaceutical and biotech industries. Its products work by integrating these services into one team from the project’s start, coordinating planning, detailed design, procurement, and construction management to align with a client's business goals and move a project from concept to operational facility. The company differentiates itself through integrated delivery across disciplines and a global footprint (five continents), supported by growth through strategic acquisitions and Berkshire Hathaway backing, which adds financial strength and scale. IPS’s goal is to help life-science clients bring critical facilities online efficiently, with predictable cost, schedule, and quality, by delivering coordinated design, engineering, and construction management under one umbrella.

Company Size

1,001-5,000

Company Stage

N/A

Total Funding

N/A

Headquarters

Philadelphia, Pennsylvania

Founded

1989

Get referred to IPS-Integrated Project Services, LLC

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • GE HealthCare named IPS lead on its Cork expansion on January 31, 2025.
  • BeiGene's $800 million Hopewell facility completed in January 2025, proving delivery at scale.
  • Revelio Labs showed 7,131 employees in March 2026, with 561 active postings across the business.

What critics are saying

  • Kinetic System v. IPS ended with adverse fee rulings on March 24, 2025, exposing contract friction.
  • IPS remains tied to capital-intensive drug plants; project cancellations quickly crush utilization and margin.
  • If biotech capex freezes through 2026, IPS loses backlog concentration and Berkshire owns a cyclical builder.

What makes IPS-Integrated Project Services, LLC unique

  • IPS integrates EPCMV across pharma and biotech, from concept through final process qualification.
  • Berkshire Hathaway ownership since 2022 gives IPS permanent capital and credibility with large customers.
  • IPS runs 29 offices across 22 countries, supporting global delivery for regulated facilities.

Help us improve and share your feedback! Did you find this helpful?

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

12%

2 year growth

12%
PR Newswire
Aug 8th, 2025
AST Names Industry Veteran Jacob Stephen as Chief Operating Officer

TACOMA, Wash., Aug. 7, 2025 /PRNewswire/ - AST is pleased to announce that Jacob Stephen will be joining the AST Team as Chief Operations Officer at the Tacoma-headquartered drug product equipment manufacturing company.

IPSDB
Mar 14th, 2025
IPS Expands Leadership in Ireland with Appointment of Karl Page

IPS expands leadership in Ireland with appointment of Karl Page.

HIT Consultant
Feb 25th, 2025
The Future Of Advanced Therapeutics: Opportunities And Challenges

Sai Bhamidipati, Pharmaceutical Regulatory Affairs ConsultantThe biopharmaceutical landscape is transforming with the advent of advanced therapeutics, including mRNA vaccines, gene therapies, and personalized medicine. These innovative treatments offer unprecedented opportunities to address complex diseases. Yet, they also present unique regulatory and manufacturing challenges that must be navigated to bring them from the laboratory to the clinic.mRNA Vaccines: Revolutionizing Disease PreventionMessenger RNA (mRNA) vaccines have gained prominence, particularly during the COVID-19 pandemic, demonstrating the potential for rapid development and high efficacy. Unlike traditional vaccines, which utilize weakened or inactivated pathogens or their protein subunits, mRNA vaccines utilize a synthetic version of the messenger RNA to instruct cells to produce a protein that elicits an immune response. This modality allows for swift adaptation to emerging pathogens and has opened avenues for vaccines targeting various diseases, including influenza and certain types of cancers.Opportunities:Rapid Development: The cell-free, scalable nature of mRNA production enables quick responses to emerging health threats.IPSDBThe cell-free, scalable nature of mRNA production enables quick responses to emerging health threats. IPSDB Versatility: mRNA vaccines can be designed to target a wide range of therapeutic areas, including but not limited to infectious diseases, Cancer-specific antigens, and rare disease areas.Challenges:Manufacturing Complexities: Scaling up production for mass production while maintaining quality and consistency poses significant challenges

IPSDB
Sep 18th, 2024
Kneat and IPS Announce Strategic Partnership

By integrating Kneat's digital validation software with IPS' technology driven delivery approach, a new benchmark for a truly digital integrated project delivery model, from concept/requirements definition through final process qualification.

IPSDB
Jul 11th, 2024
IPS Accelerates Expansion in Switzerland with New Office and Enhanced R&D Capabilities

Additionally, Integrated Project Services, LLC is excited to announce the appointment of Pia Mueller as the new Senior Manager of Laboratory Projects.